Chi Huang
Keine laufenden Positionen mehr
Karriereverlauf von Chi Huang
Ehemalige bekannte Positionen von Chi Huang
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MingMed Biotechnology Co., Ltd.
 MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Direktor/Vorstandsmitglied | - | - |
| GUANGDONG FAITH LONG CRYSTAL TECHNOLOGY CO.,LTD. | Direktor/Vorstandsmitglied | 01.11.2011 | - |
| Independent Dir/Board Member | 01.11.2011 | - |
Ausbildung von Chi Huang
| Jiangxi University of Finance & Economics | Undergraduate Degree |
Statistik
International
| China | 4 |
Operativ
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Electronic Technology | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GUANGDONG FAITH LONG CRYSTAL TECHNOLOGY CO.,LTD. | Electronic Technology |
| Private Unternehmen | 1 |
|---|---|
MingMed Biotechnology Co., Ltd.
MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
